MYBPC3 rs199473295: What Your Genotype Means
The rs199473295 variant is a specific genetic alteration located within the MYBPC3 gene. It is recognized in clinical literature as a founder variant associated with an autosomal dominant predisposition to adult-onset hypertrophic cardiomyopathy.
What each genotype means
Typical MYBPC3 profile
This genotype represents the common, non-variant sequence at this position in the MYBPC3 gene. Individuals with this genotype do not carry the specific founder variant associated with increased risk for hypertrophic cardiomyopathy at this site.
This is the most common genotype observed across all global populations.
Increased cardiomyopathy risk
This genotype indicates the presence of a founder variant in the MYBPC3 gene that is associated with an autosomal dominant predisposition to adult-onset hypertrophic cardiomyopathy. Because this condition is complex and variable, carrying this variant does not guarantee the development of heart disease, and clinical expression can differ significantly between individuals. You should discuss these findings with a cardiologist or genetic counselor to determine if clinical screening or heart monitoring is appropriate for you.
This genotype is rare globally, with a minor allele frequency of approximately 0.0003, though it is more frequently observed in South Asian populations.
Increased cardiomyopathy risk
This genotype indicates the presence of two copies of the variant, which is associated with an autosomal dominant predisposition to adult-onset hypertrophic cardiomyopathy. While the variant is typically studied in the context of single-copy inheritance, the presence of this variant warrants professional clinical evaluation. Please consult with a cardiologist or genetic counselor to discuss the implications for your heart health and potential clinical management.
This genotype is extremely rare and is not commonly reported in general population databases.
Understanding the Variant and Its Location
The rs199473295 variant is a single nucleotide polymorphism (SNP) situated within the MYBPC3 gene, which is located on chromosome 11. In the context of human genetics, SNPs represent the most common type of genetic variation, where a single building block of DNA—a nucleotide—is replaced by another. While many SNPs are benign, some occur in regions of the genome that are critical for the proper function of proteins. This specific variant is categorized under health predisposition, meaning its presence is studied for its potential role in influencing an individual's risk for certain medical conditions. Because it is located within a gene responsible for cardiac structure, researchers focus on how this change might alter the instructions the body uses to build heart muscle components. Understanding the exact location of this variant helps scientists and clinicians interpret its potential impact on cardiac health.
The Role of the MYBPC3 Gene
The MYBPC3 gene provides the essential instructions for producing a protein known as cardiac myosin-binding protein C (cMyBP-C). This protein is a vital structural component of the sarcomere, which is the basic contractile unit of heart muscle cells. By regulating the interaction between actin and myosin filaments, cMyBP-C ensures that the heart muscle contracts and relaxes with the appropriate force and rhythm. When mutations occur in this gene, they can lead to the production of an abnormal or insufficient amount of this protein, a state often referred to as haploinsufficiency. This disruption in the structural integrity of the heart muscle can interfere with its ability to pump blood efficiently. Because the heart relies on precise protein interactions to function, even minor changes in the MYBPC3 gene can have significant downstream effects on cardiac physiology, potentially leading to the thickening of the heart muscle walls.
Research Associations and Evidence Strength
Research into rs199473295 has identified it as a founder variant, meaning it is more common in specific populations due to historical migration or isolation patterns. It is primarily associated with an autosomal dominant predisposition to hypertrophic cardiomyopathy (HCM), a condition characterized by the thickening of the heart muscle. In an autosomal dominant pattern, inheriting a single copy of the variant from one parent is typically sufficient to increase the risk of developing the condition. However, the evidence strength for this specific variant is currently classified as limited. This means that while there is a documented association, the clinical understanding of its penetrance—the likelihood that an individual with the variant will actually develop symptoms—is still evolving. Clinical studies often highlight that HCM is a heterogeneous condition, and the presence of this variant does not guarantee a specific health outcome, as other genetic and environmental factors also play significant roles.
Population Frequency and Distribution
The frequency of genetic variants can vary significantly across different ancestral groups. According to data from the Genome Aggregation Database (gnomAD), the global minor allele frequency for rs199473295 is approximately 0.0003. Notably, this variant shows enrichment in South Asian populations compared to other global groups. This distribution pattern is characteristic of founder variants, which often remain concentrated within specific geographic or ethnic communities. Because the variant is relatively rare in the general global population, it is not typically included in standard, broad-spectrum genetic screening panels unless there is a specific clinical indication or family history of cardiomyopathy. The observed frequency underscores the importance of considering ancestral background when interpreting genetic test results, as a variant that is rare globally may be more common and clinically relevant within specific populations.
Navigating Genetic Information
Accessing information about genetic variants like rs199473295 can be empowering, but it is essential to approach this data with caution. This information is for educational purposes and should never be used to diagnose a medical condition or make personal health decisions. If you have concerns about your heart health or a family history of cardiomyopathy, the most appropriate step is to consult with a healthcare professional, such as a cardiologist or a genetic counselor. They can provide context based on your personal medical history, physical examinations, and, if necessary, clinical-grade genetic testing. Genetic counselors are specifically trained to help individuals understand the implications of their results, including the limitations of current research and the potential for other contributing factors. Always discuss any findings from direct-to-consumer tests or research databases with a qualified clinician before taking any action regarding your health or medical management.
How common is this variant?
The variant has a global minor allele frequency of approximately 0.0003, with notable enrichment observed in South Asian populations.
Frequently asked questions
What is hypertrophic cardiomyopathy?
Hypertrophic cardiomyopathy is a condition where the heart muscle becomes abnormally thick, which can make it harder for the heart to pump blood. It is often caused by genetic mutations in proteins that make up the heart muscle.
Does having this variant mean I will develop heart disease?
Not necessarily. While this variant is associated with a predisposition to hypertrophic cardiomyopathy, it does not guarantee that an individual will develop the condition. Many factors, including other genes and lifestyle, influence health outcomes.
Should I get tested for this variant?
Genetic testing is typically recommended by a doctor if there is a personal or family history of heart disease. You should discuss the necessity and implications of such testing with a cardiologist or a genetic counselor.
What should I do if I find this variant in my genetic report?
If you find this variant in a report, do not panic. Schedule an appointment with your primary care physician or a cardiologist to discuss the findings in the context of your overall health and family history.
Sources & further reading
Educational information only, last refreshed 10/14/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs199473295?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in MYBPC3
A common founder mutation (c.2827-2851del25) in the MYBPC3 gene strongly associated with hypertrophic cardiomyopathy in South Asian populations.
Pathogenic variant associated with hypertrophic cardiomyopathy.
A well-known pathogenic variant associated with Hypertrophic Cardiomyopathy, which causes thickening of the heart muscle.
Variant associated with endurance-focused athletic performance and exercise-induced cardiac remodeling.